Transradial Access for High-Risk Percutaneous Coronary Intervention: Implications of the Risk-Treatment Paradox.

Femoral Artery Hemorrhage Humans Percutaneous Coronary Intervention / adverse effects Radial Artery / diagnostic imaging Risk Factors Treatment Outcome
acute kidney injury hemorrhage hospitals incidence percutaneous coronary intervention

Journal

Circulation. Cardiovascular interventions
ISSN: 1941-7632
Titre abrégé: Circ Cardiovasc Interv
Pays: United States
ID NLM: 101499602

Informations de publication

Date de publication:
07 2021
Historique:
pubmed: 14 7 2021
medline: 27 10 2021
entrez: 13 7 2021
Statut: ppublish

Résumé

[Figure: see text].

Identifiants

DOI: 10.1161/CIRCINTERVENTIONS.120.009328 PMID: 34253050 PMC: PMC8895384
pubmed: 34253050
doi: 10.1161/CIRCINTERVENTIONS.120.009328
pmc: PMC8895384
mid: NIHMS1767825
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e009328

Subventions

Organisme : AHRQ HHS
ID : R18 HS022481
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000448
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR000449
Pays : United States
Organisme : NHLBI NIH HHS
ID : K23 HL146982
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002345
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR000450
Pays : United States
Organisme : NCI NIH HHS
ID : KM1 CA156708
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL146206
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Coron Artery Dis. 2019 Mar;30(2):87-92
pubmed: 30422833
JACC Cardiovasc Interv. 2013 Aug;6(8):790-9
pubmed: 23968699
Fertil Steril. 2018 Jun;109(6):946-951
pubmed: 29935652
Catheter Cardiovasc Interv. 2011 Nov 15;78(6):823-39
pubmed: 21544927
Circulation. 2013 Jun 11;127(23):2295-306
pubmed: 23753843
Exp Ther Med. 2020 Nov;20(5):42
pubmed: 32952633
Am J Cardiol. 2019 Feb 1;123(3):361-367
pubmed: 30477803
J Am Heart Assoc. 2013 May 24;2(3):e000174
pubmed: 23709565
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
J Am Coll Cardiol. 2007 Mar 27;49(12):1362-8
pubmed: 17394970
Heart. 2013 Mar;99(5):297-303
pubmed: 23322530
Cardiovasc Revasc Med. 2019 Mar;20(3):241-247
pubmed: 30030065
Heart. 2011 Nov;97(21):1753-7
pubmed: 21602521
Catheter Cardiovasc Interv. 2018 Jun;91(7):1281-1282
pubmed: 29894596
J Am Coll Cardiol. 2010 May 4;55(18):1923-32
pubmed: 20430263
Am J Cardiol. 2014 Dec 15;114(12):1830-5
pubmed: 25438909
Cochrane Database Syst Rev. 2018 Apr 18;4:CD012318
pubmed: 29665617
J Am Coll Cardiol. 2017 May 11;:
pubmed: 28528768
BMJ. 2018 Dec 10;363:k4245
pubmed: 30530757
Am Heart J. 2015 Feb;169(2):234-241.e1
pubmed: 25641532
JACC Cardiovasc Interv. 2013 Aug;6(8):814-23
pubmed: 23968700
Qual Saf Health Care. 2007 Apr;16(2):154-9
pubmed: 17403766
Am J Cardiol. 2020 Jan 1;125(1):29-33
pubmed: 31711633
Catheter Cardiovasc Interv. 2018 Dec 1;92(7):E518-E526
pubmed: 30244540
J Am Coll Cardiol. 2017 May 11;:
pubmed: 28528767
Crit Care. 2007;11(2):R31
pubmed: 17331245
JACC Cardiovasc Interv. 2017 Nov 27;10(22):2242-2254
pubmed: 29102582
J Am Coll Cardiol. 2012 Dec 18;60(24):2490-9
pubmed: 23103036
JACC Cardiovasc Interv. 2016 Jul 25;9(14):1419-34
pubmed: 27372195
Eur J Clin Invest. 2018 Jul;48(7):e12945
pubmed: 29700817
Cardiovasc Revasc Med. 2014 Sep-Oct;15(6-7):329-33
pubmed: 25282521
JACC Cardiovasc Interv. 2011 Jun;4(6):654-64
pubmed: 21700252
J Am Heart Assoc. 2014 Dec;3(6):e001380
pubmed: 25516439
Int J Epidemiol. 2016 Dec 1;45(6):2184-2193
pubmed: 27864403
JACC Cardiovasc Interv. 2013 Sep;6(9):897-904
pubmed: 24050858
Eur Heart J. 2019 Apr 14;40(15):1226-1232
pubmed: 30689825

Auteurs

Amit P Amin (AP)

Cardiovascular Division, Washington University School of Medicine, St. Louis, MO (A.P.A., M.T., R.G.B.).
Barnes-Jewish Hospital, St. Louis, MO (A.P.A., M.T., R.G.B.).

Sunil V Rao (SV)

The Duke Clinical Research Institute, Durham, NC (S.V.R.).

Arnold H Seto (AH)

Tibor Rubin Veterans Affairs Medical Center, Long Beach, CA (A.H.S.).

Manoj Thangam (M)

Cardiovascular Division, Washington University School of Medicine, St. Louis, MO (A.P.A., M.T., R.G.B.).
Barnes-Jewish Hospital, St. Louis, MO (A.P.A., M.T., R.G.B.).

Richard G Bach (RG)

Cardiovascular Division, Washington University School of Medicine, St. Louis, MO (A.P.A., M.T., R.G.B.).
Barnes-Jewish Hospital, St. Louis, MO (A.P.A., M.T., R.G.B.).

Samir Pancholy (S)

Department of Cardiology, Mercy Hospital and Community Medical Center, Scranton, PA (S.P.).

Ian C Gilchrist (IC)

Penn State University, College of Medicine, M.S. Hershey Medical Center, Hershey, PA (I.C.G.).

Prashant Kaul (P)

Piedmont Heart Institute, Atlanta, GA (P.K.).

Binita Shah (B)

Department of Medicine (Cardiology), VA New York Harbor Healthcare System and New York University School of Medicine (B.S.).

Mauricio G Cohen (MG)

Cardiovascular Division, Department of Medicine, University of Miami Miller School of Medicine, FL (M.G.C.).

Ty J Gluckman (TJ)

Center for Cardiovascular Analytics, Research and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, OR (T.J.G.).

Anna Bortnick (A)

Albert Einstein College of Medicine, Montefiore Medical Center, NY (A.B.).

James T DeVries (JT)

Department of Medicine, Section of Cardiology, Dartmouth-Hitchcock Medical Center, Geisel School of Medicine, Lebanon NH (J.T.D.).

Hemant Kulkarni (H)

M&H Research, LLC San Antonio, TX (H.K.).

Frederick A Masoudi (FA)

Division of Cardiology, Department of Medicine, University of Colorado Anschutz Medical Campus Aurora, CO (F.A.M.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Système cardiovasculaire › Vaisseaux sanguins › Artères › Artère fémorale › Transradial Access for High-Risk Percutaneous...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Hémorragie › Transradial Access for High-Risk Percutaneous...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Transradial Access for High-Risk Percutaneous...
questionsmedicales.fr › Procédures de chirurgie opératoire › Interventions chirurgicales mini-invasives › Procédures endovasculaires › Intervention coronarienne percutanée › Transradial Access for High-Risk Percutaneous...
questionsmedicales.fr › Système cardiovasculaire › Vaisseaux sanguins › Artères › Artère radiale › Transradial Access for High-Risk Percutaneous...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › Transradial Access for High-Risk Percutaneous...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Mécanismes d'évaluation des soins de santé › Évaluation des résultats et des processus en soins de santé › Évaluation de résultat (soins) › Résultat thérapeutique › Transradial Access for High-Risk Percutaneous...